Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis

Abstract

Psoriasis is a hyperproliferative and inflammatory skin disorder of unknown aetiology. A fusion protein composed of human interleukin-2 and fragments of diphtheria toxin (DAB389IL-2), which selectively blocks the growth of activated lymphocytes but not keratinocytes, was administered systemically to ten patients to gauge the contribution of activated T cells to the disease. Four patients showed striking clinical improvement and four moderate improvement, after two cycles of low dose IL-2–toxin. The reversal of several molecular markers of epidermal dysfunction was associated with a marked reduction in intraepidermal CD3+ and CD8+ T cells, suggesting a primary immunological basis for this widespread disorder.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Weinstein, G.D. & Krueger, J.G. An overview of psoriasis. in Therapy of Moderate-to-Severe Psoriasis (eds Weinstein, G. D. & Gottlieb, A.B.) 1–22 (National Psoriasis Foundation, Portland, Oregon 1993).

    Google Scholar 

  2. Vallat, V.P. et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy. J. exp. Med. 180, 283–296 (1994).

    Article  CAS  Google Scholar 

  3. Bos, J.D. et al. Predominance of “memory” T cells (CD4+, CDw29+) over “naive” T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch. dermatol. Res. 281, 24–30 (1989).

    Article  CAS  Google Scholar 

  4. Gottlieb, A.B. et al. Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J. exp. Med. 164, 1013–1028 (1986).

    Article  CAS  Google Scholar 

  5. Gottlieb, A.B., Chang, C.K., Posnett, D.N., Fanelli, B. & Tarn, J.P. Detection of transforming growth factor alpha in normal, malignant, and hyper-proliferative human keratinocytes. J. exp. Med. 167, 670–675 (1988).

    Article  CAS  Google Scholar 

  6. Elder, J.T. et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243, 811–814 (1989).

    Article  CAS  Google Scholar 

  7. Nickoloff, B.J. & Naidu, Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30, 535–546 (1994).

    Article  CAS  Google Scholar 

  8. Henseler, T. & Christophers, E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13, 450–456 (1985)

    Article  CAS  Google Scholar 

  9. Baadsgaard, O., Fisher, G., Voorhees, J.J. & Cooper, K.D. The role of the immune system in the pathogenesis of psoriasis. J. invest. Dermatol. 95, 32S–34S (1990).

    Article  CAS  Google Scholar 

  10. Chang, J.C.C. et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc. natn. Acad. Sci. U.S.A. 91, 9282–9286 (1994).

    Article  CAS  Google Scholar 

  11. Gottlieb, A.B. & Krueger, J.G. Role of T-lymphocytes (in psoriasis pathogenesis). in Psoriasis (ed. Dubertret, L.) 63–71 (ISED Publishing Co, Brescia, Italy, 1994)

    Google Scholar 

  12. Prinz, J.C. et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur. J. Immun. 24, 593–598 (1994).

    Article  CAS  Google Scholar 

  13. Bata-Csorgo, Z., Hammerberg, C., Voorhees, J.J. & Cooper, K.D. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. J. clin. Invest. 95, 317–327 (1995).

    Article  CAS  Google Scholar 

  14. Krueger, J.G. & Gottlieb, A.B. Growth factors, cytokines and eicosanoids (in psoriasis pathogenesis). in Psoriasis (ed. Dubertret, L.) 18–28 (ISED Publishing Co., Brescia, Italy, 1994)

    Google Scholar 

  15. Baker, B.S. et al. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br. J. Dermatol. 116, 503–510 (1987).

    Article  CAS  Google Scholar 

  16. Rizova, H. et al. The effect of anti-CD4 monoclonal antibody treatment on immunological changes in psoriatic skin. J. dermatol. Sci. 7, 1–13 (1994).

    Article  CAS  Google Scholar 

  17. Ackerman, C. et al. Recalcitrant psoriasis and pyoderma gangrenosum treated with FK506. J. invest. Dermatol. 96, 536 (1991).

    Google Scholar 

  18. Petzelbauer, P., Stingl, G., Wolff, K. & Volc-Platzer, B. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J. invest. Dermatol. 96, 362–369 (1991).

    Article  CAS  Google Scholar 

  19. Gottlieb, A.B. et al. Studies of the effect of cyclosporine in psoriasis in vivo: Combined effects on activated T lymphocytes and epidermal regenerative maturation. J. invest. Dermatol. 98, 302–309 (1992).

    Article  CAS  Google Scholar 

  20. Khandke, L. et al. Cyclosporine in psoriasis treatment: Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor-alpha/epidermal growth factor receptor pathways. Arch. Dermatol. 127, 1172–1179 (1991).

    Article  CAS  Google Scholar 

  21. Williams, D.P. et al. Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Engng 1, 493–498 (1987).

    Article  CAS  Google Scholar 

  22. Waters, C.A. et al. Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells. Eur. J. Immun. 20, 785–791 (1990).

    Article  CAS  Google Scholar 

  23. Waldman, T.A. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immun. Today 14, 264–270 (1993).

    Article  Google Scholar 

  24. Shaw, J.P. et al. Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J. biol. Chem. 266, 21118–21124 (1991).

    CAS  PubMed  Google Scholar 

  25. Mansbridge, J.N. & Knapp, A.M. Changes in keratinocyte maturation during wound healing. J. invest. Dermatol. 89, 253–263 (1987).

    Article  CAS  Google Scholar 

  26. Valdimarsson, H., Baker, B.S., Jonsdottir, I., Powles, A. & Fry, L. Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immun. Today 16, 145–149 (1995).

    Article  CAS  Google Scholar 

  27. Paukkonen, K., Naukkarinen, A. & Horsmanheimo, M. The development of manifest psoriatic lesions in linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch. Dermatol. Res. 284, 375–379 (1992).

    Article  CAS  Google Scholar 

  28. Onuma, A. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J. Dermatol. 21, 223–232 (1994).

    Article  CAS  Google Scholar 

  29. Gottlieb, S.L. et al. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis. A clinical and pathologic study. J. Am. Acad. Dermatol. (in the press).

  30. Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.P. & Taurog, J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2m: An animal model of HLA-B27-associated human disorders. Cell 63, 1099–1112 (1990).

    Article  CAS  Google Scholar 

  31. Carnaud, C. & Bach, J-F. Cellular basis of T-cell autoreactivity in autoimmune diseases. Immun. Res. 12, 131–148 (1993).

    Article  CAS  Google Scholar 

  32. Bacha, P.L. et al. Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy. Int. J. Cancer 49, 96–101 (1991).

    Article  CAS  Google Scholar 

  33. Krane, J.F. et al. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J. invest. Dermatol. 96, 983–986 (1991).

    Article  CAS  Google Scholar 

  34. Tomfohrde, J. et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264, 1141–1145 (1994).

    Article  CAS  Google Scholar 

  35. LeMaistre, C.F. et al. Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood 79, 2547–2554 (1992).

    Article  CAS  Google Scholar 

  36. Fredriksson, T. & Pettersson, U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157, 238–244 (1978).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gottlieb, S., Gilleaudeau, P., Johnson, R. et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1, 442–447 (1995). https://doi.org/10.1038/nm0595-442

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0595-442

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing